Thanks Jay, and good morning to everyone. Third quarter net sales were 309% over the prior year period [indiscernible] 1% compared to the third quarter of last year, but sales were up approximately 5% excluding the shipment of the previously mentioned large customer order in Q3 of last year. Legacy Interface sales in EMEA grew 6% in local currency, but grew 1% in US Dollars to do the currency headwinds driven by the Euro to USD and pound sterling to USD exchange rates versus the prior year. Legacy Interface sales in Asia, Asia Pacific were flat in local currency compared to the third quarter of last year, but were down 4% in US Dollars, largely due to the Australian dollar to USD exchange rate versus last year. In our Global Market segments, third quarter growth was driven by office, education and healthcare. Third quarter gross profit margin was 39%, up 760 basis points versus third quarter gross profit margin in the prior year period. Now adjusted gross profit margin was 39.4%, a 160 basis point improvement over adjusted gross profit margin last year. Productivity efficiencies and solid results in the Americas more than offset margin pressure from the lower than anticipated production volumes and the transactional currency impacts in EMEA and Asia Pac due to stronger currencies due to the weak dollar that we experienced in Q3 and that we've experienced throughout the year. Probably due to the strong dollar relative to the euro and due to other currencies out there, pardon me. SG&A expenses were 91 million in Q3, or 26.2% of sales. SG&A was well managed in the quarter despite unusually high legal expenses of approximately 1.7 million related to the SEC matter. Separately, we recorded restructuring charges of $672,000 associated with lease agent costs related to the decommissioning of our facility in Shelf England as we restructured our Shelf operations as part of the December 2018 restructuring plans that we previously announced at the end of last year. Looking at the operating income line, third quarter operating income was 44 million compared with 16 million in the prior year period. Adjusted operating income was 46 million in Q3 of 2019, compared to 37 million last year. In Q3, we recorded net income of 26 million or $0.45 per diluted share, up 221%, compared to net income of 8 million or $0.14 per diluted share last year. And adjusted net income was 28 million or $0.47 per diluted share in Q3 of 2019, compared to 24 million or $0.41 per diluted share last year, representing 15% growth. Trailing 12 months net income was $69 million and adjusted EBITDA was 57 million in third quarter 2019, compared to 51 million in the same period last year representing 13% growth. Moving over to the balance sheet and cash flows, our balance sheet and liquidity remain strong, with 253 million of borrowing availability under our revolving credit facility at the end of the quarter. Working capital efficiency generated 30 million of cash in the quarter as we continue to improve our working capital metrics. In addition, we repatriated 18 million of cash from foreign operations, allowing us to pay down 43 million of debt in Q3. We ended the quarter with 85 million of cash on hand and 626 million of gross debt. Net debt, which is simply gross debt minus cash on hand, was 541 million at the end of the quarter. Trailing 12 months adjusted EBITDA was 200 million at the end of Q3 2019, which resulted in a leverage ratio at the end of the quarter of 2.7, calculated as net debt divided by adjusted EBITDA. We were very pleased with the de-leveraging progress that we've made in the quarter and we remain committed to a disciplined process of de-leveraging the balance sheet. Please note these are non-GAAP measures. So as a reminder, please refer to the reconciliation tables in our press release to reconcile GAAP to non-GAAP measures. Interest expense was 7 million in the second quarter, compared to 5 million in Q3 of last year. An increase in interest expense was due to financing the Nora acquisition, which occurred in August of 2018. Depreciation and amortization was 11 million in Q3, compared to 10 million last year. Capital expenditures were 19 million in the third quarter compared to 12 million last year as we continue to execute on our strategic objectives, including expanding manufacturing capabilities and productivity initiatives. Now I'd like to hand it back to Jay to provide an update on our 2019 full year outlook.